(1S,1'S)-1,1',2,2',3,3',4,4'-Octahydro-1,1'-biisoquinoline

Catalog No. :
ACRPVJ715
CAS No. :
634180-45-3
Molecular Formula :
C18H20N2
Molecular Weight :
264.37

IUPAC Name:(1S,1'S)-1,1',2,2',3,3',4,4'-octahydro-1,1'-biisoquinoline

(1S,1'S)-1,1',2,2',3,3',4,4'-Octahydro-1,1'-biisoquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$115.00Login to see priceIn stockInquiry
250mg97%$167.00Login to see priceIn stockInquiry
1g97%$482.00Login to see priceInquiryInquiry
5g97%$2226.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1S,1'S)-1,1',2,2',3,3',4,4'-Octahydro-1,1'-biisoquinoline
IUPAC Name(1S,1'S)-1,1',2,2',3,3',4,4'-octahydro-1,1'-biisoquinoline
MDL No.-
Molecular FormulaC18H20N2
Molecular Weight264.37
SMILES[C@@]1(C=2C(CCN1)=CC=CC2)([C@@]3(C=4C(CCN3)=CC=CC4)[H])[H]
InChI KeyNDHNLLQPMVDMRO-ROUUACIJSA-N
Synonym84500-68-5 | 1,1',2,2',3,3',4,4'-Octahydro-1,1'-biisoquinoline | NSC 281678 | NSC281678 | SCHEMBL16799768 | DTXSID50314240 | BCP30040 | BCP30041 | NSC-281678 | 1,1',2,2',3,3',4,4'-Octahydro-1,1'-biisoquinoline pound>>1-(1,2,3,4-tetrahydroisoquinolin-1-yl)-1,2,3,4-tetrahydr
CAS No.634180-45-3
PubChem CID11207793

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACRPVJ715 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRPVJ715 route product structure diagram
    ACRPVJ715634180-45-3 In Stock
Inquiry

2. ACRPVJ715 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRPVJ715 route product structure diagram
    ACRPVJ715634180-45-3 In Stock
Inquiry

Comments (0)